University of Innsbruck, Institute of Pharmacy, Pharmacology and Toxicology, Center for Chemistry and Biomedicine, Innrain 80-82/III, 6020 Innsbruck, Austria.
University of Innsbruck, Institute of Pharmacy, Pharmacology and Toxicology, Center for Chemistry and Biomedicine, Innrain 80-82/III, 6020 Innsbruck, Austria.
Neuropharmacology. 2018 Apr;132:58-70. doi: 10.1016/j.neuropharm.2017.06.029. Epub 2017 Jun 29.
Channelopathies are a diverse group of human disorders that are caused by mutations in genes coding for ion channels or channel-regulating proteins. Several dozen channelopathies have been identified that involve both non-excitable cells as well as electrically active tissues like brain, skeletal and smooth muscle or the heart. In this review, we start out from the general question which ion channel genes are expressed tissue-selectively. We mined the human gene expression database Human Protein Atlas (HPA) for tissue-enriched ion channel genes and found 85 genes belonging to the ion channel families. Most of these genes were enriched in brain, testis and muscle and a complete list of the enriched ion channel genes is provided. We further focused on the tissue distribution of voltage-gated calcium channel (VGCC) genes including different brain areas and the retina based on the human gene expression from the FANTOM5 dataset. The expression data is complemented by an overview of the tissue-dependent aspects of L-type calcium channel (LTCC) function, dysfunction and pharmacology, as well as of their splice variants. Finally, we focus on the pathology of tissue-restricted LTCC channelopathies and their treatment options. This article is part of the Special Issue entitled 'Channelopathies.'
通道病是一组由编码离子通道或通道调节蛋白的基因突变引起的人类疾病。已经确定了几十种通道病,涉及非兴奋性细胞以及电活性组织,如脑、骨骼和平滑肌或心脏。在这篇综述中,我们从一般问题开始,即哪些离子通道基因在组织中具有选择性表达。我们从人类蛋白质图谱(HPA)人类基因表达数据库中挖掘组织特异性表达的离子通道基因,发现了 85 个属于离子通道家族的基因。这些基因大多在大脑、睾丸和肌肉中富集,并提供了完整的富集离子通道基因列表。我们进一步根据 FANTOM5 数据集的人类基因表达,重点研究了电压门控钙通道(VGCC)基因在不同脑区和视网膜中的组织分布。该表达数据补充了 L 型钙通道(LTCC)功能、功能障碍和药理学以及其剪接变体的组织依赖性方面的概述。最后,我们关注组织受限 LTCC 通道病的病理学及其治疗选择。本文是题为“通道病”的特刊的一部分。